Long-term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults

Leukemia and Lymphoma

Volumn 45, Issue 8, 2004, Pages 1579-1585

  Yung, L ^a   Smith, P ^g   Hancock, B W ^b   Hoskin, P ^c   Gilson, D ^d   Vernon, C ^e   Linch, D C ^a,f  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b WESTON PARK HOSPITAL   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

^d United Kingdom   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g NONE

Author keywords

Adolescence; Hodgkin's disease; Hodgkin's lymphoma; Paediatric; Treatment

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; GROUPS BY AGE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION FIELD; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED KINGDOM;

EID: 3042731977     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819042000209404     Document Type: Article

References (43)

1. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report on the Committee on Hodgkin's Disease Staging Classification", Cancer Research, 31, 1860.
2. Rosenberg, S.A., Boiron, M., DeVita, V.T., et al. (1971) "Report on the committee on Hodgkin's disease staging procedures", Cancer Research, 31, 1864.
3. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., et al. (1989) "Report of a Committee convened to discuss the evaluation and Staging of Patients with Hodgkin's disease: Cotswolds meeting", Journal of Clinical Oncology, 7(11), 1630-1636.
4. Specht, L., Gray, R.G., Clarke, M.J. and Peto, R. (1998) "Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group", Journal of Clinical Oncology, 16(3), 830-843.
5. DeVita, V.T., Jr., Serpick, A.A. and Carbone, P.P. (1970) "Combination chemotherapy in the treatment of advanced Hodgkin's disease", Annals of Internal Medicine, 73, 881-895.
6. Hancock, B.W., Vaughan, H.G., Vaughan, H.B., Haybittle, J.L., Bennett, M.H., Maclennan, K.A., et al. (1991) "British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease-long term results", British Journal of Cancer, 63(4), 579-582.
7. McElwain, T.J., Toy, J., Smith, E., Peckham, M.J. and Austin, D.E. (1977) "A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease", British Journal of Cancer, 36, 276-280.
8. Bonadonna, G., Zucali, R., Monfardini, S., De Lena, M. and Uslenghi, C. (1975) "Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP", Cancer, 36(1), 252-259.
9. Viviani, S., Bonadonna, G., Santoro, A., Bonfante, V., Zanini, M., Devizzi, L., et al. (1996) "Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results", Journal of Clinical Oncology, 14(5), 1424-1430.
10. Canellos, G.P., Anderson, J.R., Propert, K.J., Nissen, N., Cooper, M..R., Henderson, E.S., et al. (1992) "Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD", New England Journal of Medicine, 327(21), 1478-1484.
11. Duggan, D.B., Petroni, G.R., Johnson, J.L., Glick, J.H., Fisher, R.I., Connors, J.M., et al. (2003) "Randomised comparison of ABVD and MOPP/ABV hybrid for the treatment of Advanced Hodgkin's disease: report of an intergroup trial", Journal of Clinical Oncology, 21(4), 607-614.
12. Diehl, V., Franklin, J., Pfreundschuh, M., Lathan, B., Paulus, U., Hasenclever, D., et al. (2003) "Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease", New England Journal of Medicine, 348(24), 2386-2395.
13. Hancock, S.L., Donaldson, S.S. and Hoppe, R.T. (1993) "Cardiac disease following treatment of Hodgkin's disease in children and adolescents", Journal of Clinical Oncology, 11(7), 1208-1215.
14. Vaughan, H.B., Vaughan, H.G., Linch, D.C. and Anderson, L. (1994) "Late mortality in young BNLI patients cured of Hodgkin's disease", Annals of Oncology, 5(supp 2), s65-s66.
15. Ng, A.K., Bernardo, M.P., Weller, E., Backstrand, K.H., Silver, B., Marcus, K.C., et al. (2002) "Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger", Journal of Clinical Oncology, 20(8), 2101-2108.
16. Hancock, S.L., Tucker, M.A. and Hoppe, R.T. (1993) "Factors affecting late mortality from heart disease after treatment of Hodgkin's disease", Journal of American Medical Association, 270(16), 1949-1955.
17. Schellong, G. (1996) "Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group", Baillieres Clinical Haematology, 9(3), 619-634.
18. Schellong, G., Potter, R., Bramswig, J., Wagner, W., Prott, F.J., Dorffel, W., et al. (1999) "High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group", Journal of Clinical Oncology, 17(12), 3736-3744.
19. Donaldson, S.S. and Link, M.P. (1997) "Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease", Journal of Clinical Oncology, 5(5), 742-749.
20. Hutchinson, R.J., Fryer, C.J., Davis, P.C., Nachman, J., Krailo, M.D., O'Brien, R.T., et al. (1998) "MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial", Journal of Clinical Oncology, 16(3), 897-906.
21. Hunger, S.P., Link, M.P. and Donaldson, S.S. (1994) "ABVD/MOPP and low-dose involved field radiotherapy in Pediatric Hodgkin's disease: the Stanford experience", Journal of Clinical Oncology, 12(10), 2160-2166.
22. Vecchi, V., Pileri, S., Burnelli, R., Bontempi, N., Comelli, A., Testi, A.M., et al. (1993) "Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients", Cancer, 72(6), 2049-2057.
23. Vecchi, V., Burnelli, R., Di Fabio, F. and Frezza, G. (1997) "Childhood Hodgkin's disease: results of the Italian multicentric study AIEOP-MH'89-CNR", Medical Paediatric Oncology, 29(5), 434.
24. Vaughan-Hudson, B., on behalf of the British National Lymphoma Investigation. (1998) "The BNLI: Past and Present", Clinical Oncology, 10, 212-218.
25. Clarke, C.A., Glaser, S.L. and Prehn, A.W. (2001) "Age-specific survival after Hodgkin's disease in a population-based cohort (United States)", Cancer Causes Control, 12(9), 803-812.
26. Weiner, M.A., Levanthal, B.G., Marcus, R., et al. (1991) "Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group Study", Journal of Clinical Oncology, 9(9), 1591-1598.
27. British National Lymphoma Investigation. (1976) "Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation" , Lancet (1976), 991-996.
28. Jones, S.E., Haut, A., Weick, J.K., Wilson, H.E., Grozea, P., Fabian, C.J., et al. (1983) "Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study", Cancer, 51, 1339-1347.
29. Hancock, B.W., Vaughan, H.G., Vaughan, H.B., Bennett, M.H., Maclennan, K.A., Haybittle, J.L., et al. (1992) "LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial", Journal of Clinical Oncology, 10(8), 1252-1258.
30. Hancock, B.W., Gregory, W.M., Cullen, M.H., Hudson, G.V., Burton, A., Selby, P., et al. (2001) "ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial", British Journal of Cancer, 84(10), 1293-1300.
31. Cullen, M.H., Stuart, N.S., Woodroffe, C., Murphy, A., Fletcher, J., Blackledge, G.R., et al. (1994) "ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group", Journal of Clinical Oncology, 12(4), 779-787.
32. Tubiana, M., Henry-Amar, M., Hayat, M., Burgers, M., Qasim, M., Somers, R., et al. (1984) "The EORTC treatment of early stage Hodgkin's disease: the role of radiotherapy", International Journal of Radiation Oncology Biology Physics, 10, 197.
33. Swerdlow, A.J., Douglas, A.J., Hudson, G.V., Hudson, B.V., Bennett, M.H., Maclennan, K.A. (1992) "Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation", British Medical Journal, 301, 1137-1143.
34. Frezzato, M., Castaman, G. and Rodeghiero, F. (1993) "Fulminant sepsis in adults splenectomized for Hodgkin's disease", Haematologica, 78(6 suppl 2), 73-7.
35. Donaldson, S.S. and Hancock, S.L. (1996) "Second cancers after Hodgkin's disease in childhood", New England Journal of Medicine, 334(12), 792-794.
36. Yung, L. and Linch, D.C. (2003) "Seminar in Hodgkin's Lymphoma", Lancet, 361, 943-951.
37. Landman-Parker, J., Pacquement, H., Leblanc, T., Habrand, J.L., Terrier-Lacombe, M.J., Bertrand, Y., et al. (2000) "Localised childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90", Journal of Clinical Oncology, 18(7), 1500-1507.
38. Connors, J.M., Klimo, P., Adams, G., Burns, B.F., Cooper, I., Meyer, R.M., et al. (1997) "Treatment of advanced Hodgkin's disease with chemotherapy-comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group", Journal of Clinical Oncology, 15(4), 1638-1645.
39. Bhatia, S., Robison, L.L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F., et al. (1996) "Breast cancer and other second neoplasms after childhood Hodgkin's disease", New England Journal of Medicine, 334(12), 745-751.
40. Cutuli, B., Dhermain, F., Borel, C., de Larochefordiere, A., Graic, Y., de Lafontan, B., et al. (1997) "Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients", European Journal of Cancer, 33(14), 2315-2320.
41. Metayer, C., Lynch, C.F., Clarke, E.A., Glimelius, B., Storm, H., Pukkala, E., et al. (2000) "Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence", Journal of Clinical Oncology, 18(12), 2435-2443.
42. Raemaekers, J., Kluin-Nelemans, H., Teodorovic, I., Meerwaldt, C., Noordijk, E., Thomas, J., et al. (2002) "The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer", European Journal of Cancer, 38(suppl 4), S107-S113.
43. Levi, F., Lucchini, F., Negri, E., Boyle, P. and La Vecchia, C. (2002) "Trends in mortality from Hodgkin's disease in western and eastern Europe", British Journal of Cancer, 87, 291-293.